Dow Jones Newswires: Eisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
Dow Jones Newswires: Eisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
164
views
Eisai shares rose sharply Thursday morning after the U.S. Food and Drug Administration's review memo on Leqembi raised expectations for full approval of the...
Eisai shares rose sharply Thursday morning after the U.S. Food and Drug Administration's review memo on Leqembi raised expectations for full approval of the Alzheimer's drug.

Comments

https://stocktradingwebsites.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!